Prescription-Drug-Spending_Regence

Why we're addressing the growth in medication spending

By Regence | June 16, 2015

Prescription drug costs are making headlines nationwide, from the Wall Street Journal to your local business journal. Historically, we have guided our members to generic versions for cost relief. But relief is getting hard to find.

A snapshot of specialty drug costs shows why. Drawing on data from affiliated plans across the country, the Blue Cross and Blue Shield Association’s “The Health of America” report shows specialty drugs are driving the growth in medication spending. For these drugs, there are no low-cost options.

Specialty drugs for conditions like multiple sclerosis, rheumatoid arthritis, psoriasis and hepatitis C now comprise 23% of all prescription spending – and that segment rose 20% last year.

When there’s only one of a drug, we have limited bargaining power on price. But as Blue plans, together we can use our influence to shift the places they are administered to lower-cost venues.

That’s just one way we advocate for our members to make health costs more affordable and sustainable.

Learn more about The Health of America.

Share:

Recent posts

ThinkstockPhotos-542314172

Overusing antibiotics: What are the consequences?

By Regence
June 21, 2017
Dr. Mark Hiatt is an Executive Medical Director for Regence. Every week he takes to the air waves and delivers timely, relevant health information directly to consumers through his radio segment, Medical Moment. In this post, we share highlights from one of his recent segments on the overuse of antibiotics.
regence-or-rose-festival-2017-web

The Bloom Project: A Rose Festival tradition

By Regence
June 19, 2017
Learn more about Regence BlueCross BlueShield of Oregon's participation in the 2017 Portland Rose Festival.
Regence-MedSavvy-prescription-drug-costs

An Rx for rising drug costs

By Regence
June 06, 2017
Health care consumers need transparency and choice to effectively manage prescription drug costs.